Pharmaceutical company 4D pharma said it had received expedited acceptance from the UK health authorities to commence a Phase II study of a potential treatment...
Kidney disease diagnostics group Renalytix said its technology would be used by investigators from the Icahn School of Medicine at Mount Sinai to assess the...
FX risk management and payments specialist Alpha FX said Henry Lisney, chief operating officer, would be leaving the company in order to pursue future personal...